Locoregional Confinement and Major Clinical Benefit of <sup>188</sup>Re-Loaded CXCR4-Targeted Nanocarriers in an Orthotopic Human to Mouse Model of Glioblastoma.

Theranostics · 2017 · PMC5695146 · PMID 29158842

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The tests were considered as significant when p -values were less than 0.05 and highly significant when p -values were less than 0.001.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.